{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:08:32Z","timestamp":1788905312009,"version":"build-2803163510"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["DMR 1847843"],"award-info":[{"award-number":["DMR 1847843"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["1R01EB027705"],"award-info":[{"award-number":["1R01EB027705"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Biomaterials"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.celbio.2026.100578","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:51:38Z","timestamp":1788274298000},"page":"100578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Oxygen-generating cryogel vaccines help overcome tumor antigen tolerance and induce durable antitumor immunity in prostate cancer"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1691-1939","authenticated-orcid":false,"given":"Alexandra","family":"Nukovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushbu","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibault","family":"Colombani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Todorovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy M.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique M.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Losada","family":"Miguens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michail","family":"Sitkovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidi A.","family":"Bencherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Hatfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celbio.2026.100578_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.celbio.2026.100578_bib2","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1007\/s12033-024-01144-3","article-title":"Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy","volume":"67","author":"Eskandari","year":"2025","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.celbio.2026.100578_bib3","article-title":"Prostate cancer","volume":"7","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.celbio.2026.100578_bib4","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41585-023-00739-w","article-title":"Vaccines as treatments for prostate cancer","volume":"20","author":"Rastogi","year":"2023","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.celbio.2026.100578_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11523-020-00720-2","article-title":"Real-World Outcomes in First-Line Treatment of Metastatic Castration-Resistant Prostate Cancer: The Prostate Cancer Registry","volume":"15","author":"Chowdhury","year":"2020","journal-title":"Target. Oncol."},{"key":"10.1016\/j.celbio.2026.100578_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1544882","article-title":"The application of emerging immunotherapy in the treatment of prostate cancer: progress, dilemma and promise","volume":"16","author":"Che","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib7","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celbio.2026.100578_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ucl.2020.07.008","article-title":"Immunotherapy for Localized Prostate Cancer: The Next Frontier?","volume":"47","author":"Patel","year":"2020","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.celbio.2026.100578_bib9","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.urolonc.2017.09.024","article-title":"Combining immunotherapies for the treatment of prostate cancer","volume":"35","author":"Redman","year":"2017","journal-title":"Urol. Oncol.: Semin. Orig. Investig."},{"key":"10.1016\/j.celbio.2026.100578_bib10","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1158\/1078-0432.CCR-22-3832","article-title":"Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials","volume":"29","author":"Antonarakis","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.celbio.2026.100578_bib11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.18.02031","article-title":"Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer","volume":"37","author":"Gulley","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celbio.2026.100578_bib12","article-title":"420 PROSTVAC in combination with nivolumab enhanced immune cell infiltration in prostate cancer","volume":"9","author":"Bailey","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.celbio.2026.100578_bib13","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11596-025-00112-5","article-title":"mRNA Vaccines in Cancer Immunotherapy: Recent Advances, Clinical Translation, and Future Perspectives","volume":"45","author":"Pati","year":"2025","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.celbio.2026.100578_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.it.2023.11.003","article-title":"The potential of mRNA vaccines in cancer nanomedicine and immunotherapy","volume":"45","author":"Pan","year":"2024","journal-title":"Trends Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib15","series-title":"First-in-human, Dose Titration and Expansion Trial to Evaluate Safety, Immunogenicity and Preliminary Efficacy of W_pro1 (BNT112) Monotherapy and in Combination With Cemiplimab in Patients With Prostate Cancer","year":"2023"},{"key":"10.1016\/j.celbio.2026.100578_bib16","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.celbio.2026.100578_bib17","doi-asserted-by":"crossref","first-page":"277ra30","DOI":"10.1126\/scitranslmed.aaa1260","article-title":"Immunological mechanisms of the antitumor effects of supplemental oxygenation","volume":"7","author":"Hatfield","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celbio.2026.100578_bib18","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1172\/JCI137554","article-title":"Antihypoxic oxygenation agents with respiratory hyperoxia to improve cancer immunotherapy","volume":"130","author":"Hatfield","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celbio.2026.100578_bib19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41586-024-08290-3","article-title":"Evolution of myeloid-mediated immunotherapy resistance in prostate cancer","volume":"637","author":"Lyu","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.celbio.2026.100578_bib20","doi-asserted-by":"crossref","first-page":"19590","DOI":"10.1073\/pnas.1211516109","article-title":"Injectable preformed scaffolds with shape-memory properties","volume":"109","author":"Bencherif","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celbio.2026.100578_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/gels5040046","article-title":"Cryogelation and cryogels","volume":"5","author":"Rogers","year":"2019","journal-title":"Gels"},{"key":"10.1016\/j.celbio.2026.100578_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8556","article-title":"Injectable cryogel-based whole-cell cancer vaccines","volume":"6","author":"Bencherif","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2026.100578_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10591","article-title":"Biodegradable scaffolds for enhancing vaccine delivery","volume":"8","author":"Kerr","year":"2023","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.celbio.2026.100578_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121329","article-title":"Cryogel vaccines effectively induce immune responses independent of proximity to the draining lymph nodes","volume":"281","author":"Najibi","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.celbio.2026.100578_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201701469","article-title":"Injectable, Tough Alginate Cryogels as Cancer Vaccines","volume":"7","author":"Shih","year":"2018","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.celbio.2026.100578_bib26","article-title":"A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors","volume":"9","author":"Wang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2026.100578_bib27","doi-asserted-by":"crossref","first-page":"8696","DOI":"10.1021\/acsabm.4c01557","article-title":"Injectable and Degradable Zwitterionic Cryogels as Cancer Vaccine Platforms to Prevent Cancer Recurrence after Surgery","volume":"7","author":"Luo","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.celbio.2026.100578_bib28","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1021\/acs.biomac.4c00442","article-title":"Photothermal Particle-Loaded Panax Notoginseng Polysaccharide Cryogels As Personalized Tumor Vaccines","volume":"25","author":"Ni","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.celbio.2026.100578_bib29","doi-asserted-by":"crossref","DOI":"10.4028\/b-22xgN0","article-title":"Cryogel-Based Dendritic Cell Immunotherapy for Post-Surgical Breast Cancer Treatment","volume":"12","author":"Nguyen","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.celbio.2026.100578_bib30","series-title":"Engineering Technologies and Clinical Translation","first-page":"63","article-title":"Polymeric scaffolds for antitumor immune cell priming","author":"Bhatt","year":"2022"},{"key":"10.1016\/j.celbio.2026.100578_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adc8738","article-title":"Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy","volume":"8","author":"Lei","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celbio.2026.100578_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.723490","article-title":"Hydrogel-By-Design: Smart Delivery System for Cancer Immunotherapy","volume":"9","author":"Cui","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.celbio.2026.100578_bib33","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-13-0777","article-title":"Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants","volume":"74","author":"Ali","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.celbio.2026.100578_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/gels7020038","article-title":"Injectable cryogels in biomedicine","volume":"7","author":"\u00c7imen","year":"2021","journal-title":"Gels"},{"key":"10.1016\/j.celbio.2026.100578_bib35","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tibtech.2019.09.008","article-title":"Injectable Cryogels for Biomedical Applications","volume":"38","author":"Eggermont","year":"2020","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.celbio.2026.100578_bib36","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41563-018-0147-9","article-title":"Biomaterial-assisted targeted modulation of immune cells in cancer treatment","volume":"17","author":"Wang","year":"2018","journal-title":"Nat. Mater."},{"key":"10.1016\/j.celbio.2026.100578_bib37","article-title":"Modulating Adjuvant Release Kinetics From Scaffold Vaccines to Tune Adaptive Immune Responses","volume":"14","author":"Sobral","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.celbio.2026.100578_bib38","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41578-019-0106-3","article-title":"Macroscale biomaterials strategies for local immunomodulation","volume":"4","author":"Dellacherie","year":"2019","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.celbio.2026.100578_bib39","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.fmre.2022.03.009","article-title":"Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens","volume":"3","author":"Zhang","year":"2022","journal-title":"Fundam. Res."},{"key":"10.1016\/j.celbio.2026.100578_bib40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.actbio.2017.11.024","article-title":"Injectable nanocomposite cryogels for versatile protein drug delivery","volume":"65","author":"Koshy","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.celbio.2026.100578_bib41","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.polymer.2008.01.027","article-title":"Hydrogels in drug delivery: Progress and challenges","volume":"49","author":"Hoare","year":"2008","journal-title":"Polymer"},{"key":"10.1016\/j.celbio.2026.100578_bib42","article-title":"Sustained Vaccine Exposure Elicits More Rapid, Consistent, and Broad Humoral Immune Responses to Multivalent Influenza Vaccines","volume":"12","author":"Saouaf","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.celbio.2026.100578_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114897","article-title":"Long-acting vaccine delivery systems","volume":"198","author":"Walvekar","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.celbio.2026.100578_bib44","doi-asserted-by":"crossref","first-page":"E6639","DOI":"10.1073\/pnas.1606050113","article-title":"Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination","volume":"113","author":"Tam","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celbio.2026.100578_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/jbm.a.70074","article-title":"Evolving Transport Properties of Dynamic Hydrogels Enable Self-Tuning of Short- and Long-Term Cargo Delivery","volume":"114","author":"Sen","year":"2026","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.celbio.2026.100578_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.114564","article-title":"Antigen-conjugated scaffolds enable sustained delivery of antigen and enrichment of antigen-specific T-cells","volume":"390","author":"Wheeler","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.celbio.2026.100578_bib47","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.4049\/jimmunol.167.11.6140","article-title":"Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions","volume":"167","author":"Caldwell","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib48","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.1113560109","article-title":"Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials","volume":"109","author":"Pedraza","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celbio.2026.100578_bib49","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/s41577-024-01087-5","article-title":"How oxygenation shapes immune responses: emerging roles for physioxia and pathological hypoxia","volume":"25","author":"Mirchandani","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib50","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celbio.2026.100578_bib51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.22.012703.104731","article-title":"Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors","volume":"22","author":"Sitkovsky","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib52","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nri1685","article-title":"Regulation of immune cells by local-tissue oxygen tension: HIF1\u03b1 and adenosine receptors","volume":"5","author":"Sitkovsky","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.570041","article-title":"Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy","volume":"11","author":"Steingold","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib54","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.174675","article-title":"Oxygen-carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia\u2013induced immunosuppression","volume":"10","author":"Halpin-Veszeleiova","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.celbio.2026.100578_bib55","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00109-013-1001-9","article-title":"Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer","volume":"91","author":"Sitkovsky","year":"2013","journal-title":"J. Mol. Med. (Berl)"},{"key":"10.1016\/j.celbio.2026.100578_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1278397","article-title":"Biomaterial-assisted local oxygenation safeguards the prostimulatory phenotype and functions of human dendritic cells in hypoxia","volume":"14","author":"Bhatt","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib57","article-title":"Oxygen-Generating Cryogels Restore T Cell Mediated Cytotoxicity in Hypoxic Tumors","volume":"31","author":"Colombani","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.celbio.2026.100578_bib58","doi-asserted-by":"crossref","unstructured":"Bhatt, K., Colombani, T., Nukovic, A., Parekh, N., Hamrangsekachaee, M., Rogers, Z.J., Sitkovsky, M., Hatfield, S.M., and Bencherif, S.A. (2026). Bioengineered cryogels overcome hypoxia-driven tolerance and restore antitumor immunity. Cell Biomater. https:\/\/doi.org\/10.1016\/j.celbio.2026.100417.","DOI":"10.1016\/j.celbio.2026.100417"},{"key":"10.1016\/j.celbio.2026.100578_bib59","article-title":"Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID-19 Vaccines","volume":"8","author":"Colombani","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.celbio.2026.100578_bib60","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1021\/acsbiomaterials.5c00134","article-title":"Biomolecule Conjugation Strategy for HAGM Cryogels to Create 3D Immune Niches that Induce Multifunctional T Cells","volume":"11","author":"Schluck","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.celbio.2026.100578_bib61","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0891-5849(98)00194-4","article-title":"Reactive oxygen species activate human peripheral blood dendritic cells","volume":"26","author":"Rutault","year":"1999","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.celbio.2026.100578_bib62","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.freeradbiomed.2011.11.022","article-title":"Modulatory effects of low-dose hydrogen peroxide on the function of human plasmacytoid dendritic cells","volume":"52","author":"Pazmandi","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.celbio.2026.100578_bib63","article-title":"Polymer oxidation: A strategy for the controlled degradation of injectable cryogels","volume":"32","author":"Nukovic","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.celbio.2026.100578_bib64","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.biotechadv.2007.07.001","article-title":"The many ways to cleave hyaluronan","volume":"25","author":"Stern","year":"2007","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.celbio.2026.100578_bib65","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/glycob\/cwq171","article-title":"Oxidative depolymerization of polysaccharides by reactive oxygen\/nitrogen species","volume":"21","author":"Duan","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.celbio.2026.100578_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00740","article-title":"Fc\u03b3R Binding and ADCC Activity of Human IgG Allotypes","volume":"11","author":"de Taeye","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1158\/2326-6066.CIR-16-0114","article-title":"Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery","volume":"5","author":"Mosely","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.celbio.2026.100578_bib68","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1172\/JCI96268","article-title":"Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy","volume":"128","author":"Jayaprakash","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.celbio.2026.100578_bib69","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/10837450.2026.2621220","article-title":"Recent Advancements In Cancer Vaccine Developments: Novel Approaches","volume":"31","author":"Ejeta","year":"2026","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.celbio.2026.100578_bib70","article-title":"Pipe dream to pipeline: Journey of cancer vaccines and the road ahead","volume":"7","author":"Onkar","year":"2026","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.celbio.2026.100578_bib71","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1052934","article-title":"Oxygenation to improve cancer vaccines, adoptive cell transfer and blockade of immunological negative regulators","volume":"4","author":"Hatfield","year":"2015","journal-title":"OncoImmunology"},{"key":"10.1016\/j.celbio.2026.100578_bib72","article-title":"Engineering hyaluronic acid-based cryogels for CD44-mediated breast tumor reconstruction","volume":"13","author":"Rezaeeyazdi","year":"2022","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.celbio.2026.100578_bib73","doi-asserted-by":"crossref","first-page":"H41","DOI":"10.1002\/adma.201003963","article-title":"Hyaluronic Acid Hydrogels for Biomedical Applications","volume":"23","author":"Burdick","year":"2011","journal-title":"Adv. Mater."},{"key":"10.1016\/j.celbio.2026.100578_bib74","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijbiomac.2006.09.019","article-title":"Synthesis and degradation test of hyaluronic acid hydrogels","volume":"40","author":"Hahn","year":"2007","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.celbio.2026.100578_bib75","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bcdf.2015.09.005","article-title":"Barley \u03b2-glucan cryogels as encapsulation carriers of proteins: Impact of molecular size on thermo-mechanical and release properties","volume":"6","author":"Lazaridou","year":"2015","journal-title":"Bioact. Carbohydr. Diet. Fibre"},{"key":"10.1016\/j.celbio.2026.100578_bib76","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1039\/C1SM06589K","article-title":"Hydrogels with well-defined peptide-hydrogel spacing and concentration: impact on epithelial cell behavior","volume":"8","author":"Wilson","year":"2011","journal-title":"Soft Matter"},{"key":"10.1016\/j.celbio.2026.100578_bib77","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41565-025-01925-0","article-title":"Better the devil you know than the devil you don\u2019t\u2014PEG challenges in nanomedicine","volume":"20","author":"Dobrovolskaia","year":"2025","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.celbio.2026.100578_bib78","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.coi.2019.04.003","article-title":"Antigen presentation by dendritic cells for B cell activation","volume":"58","author":"Heath","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib79","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.coi.2018.04.005","article-title":"Role of calcium permeable channels in dendritic cell migration","volume":"52","author":"S\u00e1ez","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib80","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1021\/acsnano.4c00550","article-title":"Modulation of Dendritic Cell Function via Nanoparticle-Induced Cytosolic Calcium Changes","volume":"18","author":"Cao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.celbio.2026.100578_bib81","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s13238-020-00707-9","article-title":"Memory T cells: strategies for optimizing tumor immunotherapy","volume":"11","author":"Liu","year":"2020","journal-title":"Protein Cell"},{"key":"10.1016\/j.celbio.2026.100578_bib82","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1007\/PL00014051","article-title":"The critical role of Th-1 dominant immunity in tumor immunology","volume":"46","author":"Nishimura","year":"2000","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.celbio.2026.100578_bib83","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2024.02.015","article-title":"Dual checkpoint T(h1)eamwork makes the anti-cancer dream work","volume":"57","author":"Dietl","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.celbio.2026.100578_bib84","doi-asserted-by":"crossref","first-page":"6432","DOI":"10.1182\/bloodadvances.2025017873","article-title":"Predictive markers for the efficacy of CAR T-cell therapy: the interplay between CAR T-cell fitness and systemic immunity","volume":"9","author":"Yoo","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.celbio.2026.100578_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-024-01193-6","article-title":"Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies","volume":"14","author":"Tao","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.celbio.2026.100578_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66737-1","article-title":"Multiplex gene-editing strategy to engineer allogeneic EGFR-targeting CAR T-cells with improved efficacy against solid tumors","volume":"16","author":"Murray","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celbio.2026.100578_bib87","doi-asserted-by":"crossref","DOI":"10.1111\/sji.70084","article-title":"From Neoantigen Discovery to Immune-Checkpoint Synergy: Peptide Cancer Vaccines as Precision Tools for Personalised Cancer Therapy","volume":"103","author":"Banday","year":"2026","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.celbio.2026.100578_bib88","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.biomaterials.2007.11.047","article-title":"Influence of the degree of methacrylation on hyaluronic acid hydrogels properties","volume":"29","author":"Bencherif","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.celbio.2026.100578_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/ma11081374","article-title":"Injectable Hyaluronic Acid-co-Gelatin Cryogels for Tissue-Engineering Applications","volume":"11","author":"Rezaeeyazdi","year":"2018","journal-title":"Materials (Basel)"}],"container-title":["Cell Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050562326002345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050562326002345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T21:28:20Z","timestamp":1788902900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050562326002345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":89,"alternative-id":["S3050562326002345"],"URL":"https:\/\/doi.org\/10.1016\/j.celbio.2026.100578","relation":{},"ISSN":["3050-5623"],"issn-type":[{"value":"3050-5623","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxygen-generating cryogel vaccines help overcome tumor antigen tolerance and induce durable antitumor immunity in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celbio.2026.100578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100578"}}